Wei Li Adeline Koay

Wei Li Adeline Koay

Auto-generated profile, based on publicly available information

Wei Li Adeline Koay

Division of Infectious Diseases, Children's National Hospital, Washington, District of Columbia, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2019 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
STSusan A Tuddenham
Susan A Tuddenham
WKWei Li A Koay
Wei Li A Koay
NZNi Zhao
Ni Zhao
JWJames R White
James R White
KGKhalil G Ghanem
Khalil G Ghanem
CSCynthia L Sears
Cynthia L Sears
Whether human immunodeficiency virus (HIV) infection impacts gut microbial α-diversity is controversial. We reanalyzed raw 16S ribosomal RNA (rRNA) gene sequences and metadata from published studies to examine α-diversity measures between HIV-uninfected (HIV–) and HIV-infected (HIV+) individuals. We conducted a systematic review and individual level meta-analysis by searching Embase, Medline, and Scopus for original research studies (inception to 31 December 2017). Included studies reported 16S rRNA gene sequences of fecal samples from HIV+ patients. Raw sequence reads and metadata were obtained from public databases or from study authors. Raw reads were processed through standardized pipelines with use of a high-resolution taxonomic classifier. The χ2 test, paired t tests, and generalized linear mixed models were used to relate α-diversity measures and clinical metadata. Twenty-two studies were identified with 17 datasets available for analysis, yielding 1032 samples (311 HIV–, 721 HIV+). HIV status was associated with a decrease in measures of α-diversity (P < .001). However, in stratified analysis, HIV status was associated with decreased α-diversity only in women and in men who have sex with women (MSW) but not in men who have sex with men (MSM). In analyses limited to women and MSW, controlling for HIV status, women displayed increased α-diversity compared with MSW. Our study suggests that HIV status, sexual risk category, and gender impact gut microbial community α-diversity. Future studies should consider MSM status in gut microbiome analyses.

1 January 2018 in Current Opinion in HIV and AIDS
Verified
Journal Article
Closed access
WKWei Li A. Koay
Wei Li A. Koay
LSLilly V. Siems
Lilly V. Siems
DPDeborah Persaud
Deborah Persaud
Purpose of review This article discusses the interaction between HIV infection, the gut microbiome, inflammation and immune activation, and HIV reservoirs, along with interventions to target the microbiome and their implications for HIV remission and cure. Recent findings Most studies show that HIV-infected adults have a gut microbiome associated with decreased bacterial richness and diversity, and associated systemic inflammation and immune activation. A unique set of individuals, elite controllers, who spontaneously control HIV replication, have a similar microbiome to HIV-uninfected individuals. Conversely, exposure to maternal HIV in infants was shown to alter the gut microbiome, even in infants who escaped perinatal infection. Emerging research highlights the importance of the metabolomics and metaproteomics of the gut microbiome, which may have relevance for HIV remission and cure. Together, these studies illustrate the complexity of the relationship between HIV infection, the gut microbiome, and its systemic effects. Summary Understanding the association of HIV with the microbiome, metabolome, and metaproteome may lead to novel therapies to decrease inflammation and immune activation, and impact HIV reservoir size and vaccine responses. Further research in this area is important to inform HIV remission and cure treatments.

1 March 2020 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
STSusan Tuddenham
Susan Tuddenham
WKWei Li Koay
Wei Li Koay
CSCynthia Sears
Cynthia Sears

1 July 2021 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
WKWei Li A Koay
Wei Li A Koay
SDSahera Dirajlal-Fargo
Sahera Dirajlal-Fargo
MLMatthew E Levy
Matthew E Levy
PKPaige Kulie
Paige Kulie
AMAnne Monroe
Anne Monroe
NRNatella Y Rakhmanina
Natella Y Rakhmanina
We conducted a retrospective analysis of 38 children and youth with human immunodeficiency virus (aged 0–19 years) in the United States and report an increased rate of change of BMI-for-age z score after initiating integrase strand transfer inhibitors (+0.19 z score units/year [95% confidence interval, .01–.37]; P = .036) for a median follow-up of 527.5 days.

12 May 2018 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
WKWei Li A Koay
Wei Li A Koay
JLJane C Lindsey
Jane C Lindsey
PUPriyanka Uprety
Priyanka Uprety
MBMutsa Bwakura-Dangarembizi
Mutsa Bwakura-Dangarembizi
AWAdriana Weinberg
Adriana Weinberg
DPDeborah Persaud
Deborah Persaud
Intestinal fatty acid binding protein (iFABP) levels did not differ between human immunodeficiency virus type 1 (HIV-1)– infected infants and uninfected infants exposed to HIV-1, but those who breastfed had substantially lower levels. Zonulin levels increased from 3 to 5.3 months of age with perinatal acquisition of HIV-1 despite early antiretroviral treatment. Biomarkers of intestinal integrity (ie, iFABP and zonulin) were compared in 56 HIV-1–positive African infants who received early antiretroviral treatment and 53 HIV-1–exposed but uninfected (HEU) controls. Despite heightened inflammation and immune activation in HIV-positive infants, iFABP and zonulin levels at 3 months of age were not different from those in HEU infants and largely were not correlated with inflammatory and immune activation biomarkers. However, zonulin levels increased and became significantly higher in HIV-positive infants as compared to HEU infants by 5 months of age, despite viral suppression due to antiretroviral treatment. These findings have implications for intestinal integrity biomarker profiling in perinatal HIV-1 infection.

21 September 2020 in The Journal of Pediatrics
Verified
Journal Article
Closed access
WKWei Li A. Koay
Wei Li A. Koay
JZJiaqi Zhang
Jiaqi Zhang
KMKrishna V. Manepalli
Krishna V. Manepalli
CGCaleb J. Griffith
Caleb J. Griffith
ACAmanda D. Castel
Amanda D. Castel
NRNatella Y. Rakhmanina
Natella Y. Rakhmanina